Related Experiment Video
Updated: Jun 19, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Intranasal Versus Buccal Versus Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures in
Maha Z Mohammed1, Iman Elagouza1, Maha El Gaafary2
1Faculty of Medicine, Department of Pediatrics, Ain Shams University, Cairo, Egypt.
Insights
Midazolam is effective for treating acute seizures in children across buccal, intranasal, and intramuscular routes. No significant differences in efficacy were found, though intranasal administration offered the highest caregiver satisfaction.
Area of Science:
- Pediatric Emergency Medicine
- Pharmacology
- Neurology
Background:
- Benzodiazepines are first-line treatments for acute seizures.
- Midazolam is a key benzodiazepine used in seizure management.
- Comparing administration routes is crucial for optimizing pediatric care.
Purpose of the Study:
- To compare the efficacy, side effects, and satisfaction of midazolam administered via buccal, intranasal, or intramuscular routes.
- To evaluate midazolam's effectiveness in treating acute seizures in children in both home and emergency room settings.
- To determine the optimal route for midazolam administration in pediatric seizure emergencies.
Main Methods:
- Prospective, randomized, controlled trial involving children aged one month to 17 years.
- Primary endpoint: seizure cessation within 10 minutes and no recurrence within 30 minutes.
- Data collected on efficacy, side effects, and caregiver satisfaction across different administration routes.
Main Results:
- High efficacy rates for all midazolam routes: intramuscular (94.2% home, 85.3% ER), intranasal (93.3% home, 88.2% ER), and buccal (91% home, 78.4% ER).
- No statistically significant differences in efficacy were observed between the buccal, intranasal, and intramuscular routes in either setting (P=0.763 home, P=0.509 ER).
- No significant cardiorespiratory events were reported across any treatment groups.
Conclusions:
- Intramuscular, intranasal, and buccal midazolam effectively resolve most acute seizures in prehospital and emergency settings.
- There is no statistically significant difference in efficacy among the different routes of midazolam administration.
- The intranasal route demonstrated the highest satisfaction rate among caregivers, suggesting a preference for this method.
Background:
Benzodiazepines are the recommended first-line treatment of acute seizures. We wished to compare the efficacy, side effects, and satisfaction after midazolam administration by the buccal, intranasal, or intramuscular route in the treatment of acute seizures in children at homes and in emergency room (ER).
Methods:
A prospective, randomized, controlled trial was performed in children aged one month to 17 years with acute seizures lasting longer than five minutes. The primary end point was seizure cessation within 10 minutes of drug administration and no seizure recurrence within 30 minutes.
Results:
In the home group, 67 patients received midazolam via buccal route, 60 via intranasal route, and 69 via intramuscular route, whereas in the ER group, 37 patients received buccal, 34 received intranasal, and 34 received intramuscular midazolam. The primary end point was achieved in 94.2% and 85.3% after intramuscular midazolam in the home and ER groups, respectively. The intranasal midazolam was successful in stopping seizures in 93.3% in the home group and 88.2% in the ER group. The buccal route was effective in 91% in the home group and 78.4% in the ER group. There were no significant differences in efficacy between all groups (P = 0.763 and P = 0.509) among the home and ER groups, respectively. There were no significant cardiorespiratory events in all groups.
Conclusions:
Intramuscular, intranasal, and buccal doses of midazolam resolved most seizures in prehospital and emergency settings. Our results indicate that there is no statistically significant difference detected between different routes of midazolam. Intranasal route showed the highest satisfaction rate among caregivers.
More Related Videos
Related Concept Videos
Drug Delivery: Enteral Route
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Depolarizing Blockers: Pharmocokinetics
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

